Genesis HealthCare approved for sale to new buyer

Summary

Genesis HealthCare filed for Chapter 11 bankruptcy in July 2025, initiating a process in which its controlling private equity-linked owners had unsuccessfully sought to retain control of the company while restructuring its debts and liabilities.

During the bankruptcy, Genesis had pursued an insider-backed transaction led by affiliates of its existing private equity owners including ReGen Healthcare, an entity controlled by Genesis majority shareholder Joel Landau. The proposal would have reduced debts and medical malpractice claims while leaving ownership unchanged, with the same controlling group remaining in control of Genesis after the Chapter 11 process.

The proposed insider transaction drew scrutiny from federal lawmakers. In October 2025, several lawmakers requested information from Genesis and its private equity owner related to whether Genesis was using bankruptcy to avoid paying victims and families; in November 2025, some of those lawmakers called for the U.S. Trustee to investigate whether Genesis was “attempting to exploit the bankruptcy system at the expense of victims, workers, and other businesses;” and in December  those lawmakers filed an amicus brief urging the bankruptcy court to appoint an independent examiner.

In December, a U.S. bankruptcy judge refused to approve the proposed sale to insiders and ordered Genesis to restart the auction process. The judge noted that the deal could have eliminated as much as $100 million in potential claims against Genesis insiders. Instead, she stated that the new process should give a larger role to creditors and should not include releases shielding insiders from legal claims.

In January, the court approved a sale valued at roughly $1 billion to a bidder backed by NewGen Health, operating under the name “101 West State Street,” concluding the auction process that followed the court’s earlier rejection. NewGen had not participated in the earlier auction and, according to testimony from its chief financial officer, Genesis insiders were not involved in NewGen’s acquisition of Genesis.

At the sale hearing, one attorney representing 345 plaintiffs against Genesis said the deal would allow junior creditors to recover up to 30 percent of their claims, compared with 17 percent under the failed insider-backed proposal. The judge also emphasized that the sale does not release legal claims against Genesis insiders, including its current private equity owners.

Background and Bankruptcy

In 2007, private equity firm Formation Capital, along with JER Partners, acquired Genesis in a $1.7 billion leveraged buyout financed in part with debt carried on Genesis’s own books, meaning the company became responsible for repaying the loans used by the private equity firms to buy it.

While Formation controlled Genesis, it completed a major real estate transaction that generated cash for investors. In 2011, Genesis sold 147 facilities to Health Care REIT (now Welltower) for $2.4 billion. That sale brought cash to investors but removed Genesis of property ownership and saddled the company with a long-term lease as a tenant on real estate it previously owned.

Formation had previously leveraged a similar approach at LaVie Care Centers (also known as Consulate Health Care), a nursing home chain under its ownership beginning in 2014, which entered bankruptcy in 2024 with over $1.1 billion in liabilities, including $622 million tied to facility lease obligations.

As Genesis approached financial distress, entities including ReGen Healthcare assumed control in 2021 through a transaction giving ReGen a 93 percent equity stake and the right to appoint three members of the board, positioning it as the company’s controlling owner at the time of the bankruptcy.

At the time of its bankruptcy filing, Genesis reported more than $2.3 billion in debt and was operating about 175 skilled nursing and assisted living facilities across 18 states. The company faced hundreds of lawsuits alleging malpractice, wrongful death, or other injuries, and stated it owed at least $259 million to plaintiffs, while plaintiffs’ attorneys said the company’s total liability exposure was higher

Genesis had entered into at least 155 settlement agreements in patient injury and  death cases in the years before filing for bankruptcy, according to KFF Health News. The agreements included provisions allowing it to delay payment, and when Genesis filed for Chapter 11, it still owed roughly $41 out of $58 million due under those settlement agreements.

Private Equity’s Relevance

PESP’s bankruptcy tracker shows that private equity-owned companies have had a disproportionately large role in U.S. bankruptcies. PESP research  also shows that the opaque nature of the private equity industry obscures nursing home ownership  making it difficult to identify and assess risk, even as bankruptcies persist across the sector.

Oversight of nursing home ownership depends in part on timely and accurate disclosure of who controls facilities and related entities. However, in December 2025, CMS suspended the off-cycle nursing home revalidation process that had been designed to collect detailed ownership and control information, reducing near-term transparency around private equity involvement.

Genesis HealthCare’s Chapter 11 filings shows how the bankruptcy process can be used to attempt to preserve private equity control while restructuring liabilities, and how court oversight can alter that trajectory. As private equity ownership remains prevalent in nursing homes, the case underscores the continuing importance of transparency around who owns and controls healthcare providers.